Using the ROC curve for gauging treatment effect in clinical trials
暂无分享,去创建一个
[1] J. L. Hodges,et al. The Efficiency of Some Nonparametric Competitors of the t-Test , 1956 .
[2] P. Rothwell. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation , 2005, The Lancet.
[3] R. Iman,et al. Rank Transformations as a Bridge between Parametric and Nonparametric Statistics , 1981 .
[4] M. Pepe. The Statistical Evaluation of Medical Tests for Classification and Prediction , 2003 .
[5] S. Pocock,et al. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practiceand problems , 2002, Statistics in medicine.
[6] J. Hanley. Receiver operating characteristic (ROC) methodology: the state of the art. , 1989, Critical reviews in diagnostic imaging.
[7] Lori E. Dodd,et al. Semiparametric Regression for the Area Under the Receiver Operating Characteristic Curve , 2003 .
[8] W W Hauck,et al. Should we adjust for covariates in nonlinear regression analyses of randomized trials? , 1998, Controlled clinical trials.
[9] C B Begg,et al. A General Regression Methodology for ROC Curve Estimation , 1988, Medical decision making : an international journal of the Society for Medical Decision Making.
[10] T Hyslop,et al. Generalized treatment effects for clinical trials. , 2000, Statistics in medicine.
[11] R L Iman,et al. Analysis of covariance using the rank transformation. , 1982, Biometrics.
[12] Margaret S. Pepe,et al. A regression modelling framework for receiver operating characteristic curves in medical diagnostic testing , 1997 .
[13] D. DeMets,et al. Fundamentals of Clinical Trials , 1982 .
[14] H. B. Mann,et al. On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other , 1947 .
[15] Douglas A. Wolfe,et al. Nonparametric Statistical Methods , 1973 .
[16] P Armitage,et al. Importance of prognostic factors in the analysis of data from clinical trials. , 1981, Controlled clinical trials.
[17] F. Wilcoxon. Individual Comparisons by Ranking Methods , 1945 .
[18] John A. Swets,et al. Evaluation of diagnostic systems : methods from signal detection theory , 1982 .
[19] M S Pepe,et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. , 1999, The New England journal of medicine.
[20] P. O'Brien,et al. Comparing Two Samples: Extensions of the t, Rank-Sum, and Log-Rank Tests , 1988 .
[21] A. Cantin,et al. Cystic fibrosis lung inflammation: early, sustained, and severe. , 1995, American journal of respiratory and critical care medicine.
[22] C Brownie,et al. A rank-based mixed model approach to multisite clinical trials. , 1992, Biometrics.
[23] D. Bamber. The area above the ordinal dominance graph and the area below the receiver operating characteristic graph , 1975 .
[24] J. J. Higgins,et al. A Comparison of the Power of Wilcoxon's Rank-Sum Statistic to that of Student'st Statistic Under Various Nonnormal Distributions , 1980 .
[25] Margaret Sullivan Pepe,et al. The Analysis of Placement Values for Evaluating Discriminatory Measures , 2004, Biometrics.
[26] J. Hanley,et al. The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.
[27] Douglas A. Wolfe,et al. On Constructing Statistics and Reporting Data , 1971 .
[28] David Faraggi,et al. Adjusting receiver operating characteristic curves and related indices for covariates , 2003 .
[29] W W Hauck,et al. A consequence of omitted covariates when estimating odds ratios. , 1991, Journal of clinical epidemiology.